MYGN Financial Facts

Income tax provision (benefit): 33.78M
Total costs and expenses: 121.06M
See Full Income Statement

Equipment: 80.69M
Accrued liabilities: 56.41M
See Full Balance Sheet

Myriad Genetics Inc. (MYGN) Earnings

  |   Expand Research on MYGN
Next EPS Date 11/5/14 *Est. EPS Growth Rate -9.4% *Last Qtr.
Average EPS % Beat Rate +25.6% Revenue Growth Rate +8.4% *Last Qtr.
Average % Move 1-Wk after EPS +1.0% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/2/10 Q111 $0.24$0.23 +$0.01N/AN/A Details
5/3/11 Q311 $0.31$0.25 +$0.06$102.4M$98.11M Details
1/27/11 Q211 $0.26$0.26 $0.00$100.4M$98.84M Details
11/1/11 Q112 $0.29$0.28 +$0.01$110.5M$106.49M = Details
8/9/11 Q411 $0.30$0.29 +$0.01$107.4M$104.43M = Details
1/31/12 Q212 $0.33$0.31 +$0.02$122.8M$115.28M = Details
11/5/12 Q113 $0.36$0.32 +$0.04$133.44M$129.43M Details
5/1/12 Q112 $0.34$0.32 +$0.02$129.8M$119.2M = Details